{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:36Z","timestamp":1790959176865,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejps.2021.105735","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T18:33:55Z","timestamp":1611858835000},"page":"105735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["A grafted copolymer-based nanomicelles for topical ocular delivery of everolimus: Formulation, characterization, ex-vivo permeation, in-vitro ocular toxicity, and stability study"],"prefix":"10.1016","volume":"159","author":[{"given":"Nikita","family":"Mehra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd.","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.105735_bib0001","series-title":"Ocular Drug delivery: advances, Challenges and Applications","author":"Addo","year":"2016"},{"key":"10.1016\/j.ejps.2021.105735_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ph12010015","article-title":"Micellisation mechanism and behaviour of Soluplus\u00ae\u2013furosemide micelles: preformulation studies of an oral nanocarrier-based system","volume":"12","author":"Alopaeus","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2021.105735_bib0003","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.xphs.2016.03.006","article-title":"\u03b1-Lipoic acid in Soluplus\u00ae polymeric nanomicelles for ocular treatment of diabetes-associated corneal diseases","volume":"105","author":"Alvarez-Rivera","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105735_bib0004","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10856-012-4562-1","article-title":"Self-assembled nanomicelles using PLGA\u2013PEG amphiphilic block copolymer for insulin delivery: a physicochemical investigation and determination of CMC values","volume":"23","author":"Ashjari","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ejps.2021.105735_bib0005","first-page":"50","article-title":"In vitro delivery of nano-and micro-particles to retinal pigment epithelial (RPE) cells","volume":"2","author":"Aukunuru","year":"2002","journal-title":"Drug Deliv. Technol."},{"key":"10.1016\/j.ejps.2021.105735_bib0006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2018.03.003","article-title":"In vitro and ex vivo correlation of drug release from ophthalmic ointments","volume":"276","author":"Bao","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2021.105735_bib0007","article-title":"Epidemiology and pathogenesis of uveitis: a review","volume":"1","author":"Biswas","year":"2017","journal-title":"Indian J. Inflam. Res."},{"key":"10.1016\/j.ejps.2021.105735_bib0008","first-page":"907","article-title":"Cyclosporin and treatment of non-infectious and recurrent uveitis (apropos of a case of bilateral uveopapillitis)","volume":"88","author":"Boizeau","year":"1988","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"10.1016\/j.ejps.2021.105735_bib0009","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1016\/S2214-109X(17)30293-0","article-title":"Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis","volume":"5","author":"Bourne","year":"2017","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.ejps.2021.105735_bib0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1556\/avet.58.2010.3.9","article-title":"HET-CAM test for determining the possible eye irritancy of pesticides","volume":"58","author":"Budai","year":"2010","journal-title":"Acta Vet. Hung."},{"key":"10.1016\/j.ejps.2021.105735_bib0011","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-014-0244-2","article-title":"Nanomicellar topical aqueous drop formulation of rapamycin for back-of-the-eye delivery","volume":"16","author":"Cholkar","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2021.105735_bib0012","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1208\/s12249-014-0159-y","article-title":"Optimization of dexamethasone mixed nanomicellar formulation","volume":"15","author":"Cholkar","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2021.105735_bib0013","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.74.6.344","article-title":"Cyclosporin in the treatment of severe chronic idiopathic uveitis","volume":"74","author":"De Vries","year":"1990","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2021.105735_bib0014","doi-asserted-by":"crossref","DOI":"10.1089\/jop.2019.0109","article-title":"Micelles: promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases","author":"Durgun","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2021.105735_bib0015","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2021.105735_bib0016","article-title":"Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets","volume":"6","author":"Gouda","year":"2017","journal-title":"J. Dev. Drugs"},{"key":"10.1016\/j.ejps.2021.105735_bib0017","doi-asserted-by":"crossref","first-page":"12968","DOI":"10.1038\/srep12968","article-title":"Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation","volume":"5","author":"Guo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2021.105735_bib0018","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/00002512-200623070-00001","article-title":"Chronic non-infectious uveitis in the elderly","volume":"23","author":"Gupta","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejps.2021.105735_bib0019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exer.2012.09.003","article-title":"Everolimus improves experimental autoimmune uveoretinitis","volume":"105","author":"Hennig","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejps.2021.105735_bib0020","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"10.1016\/j.ejps.2021.105735_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1872211308666140130093301","article-title":"Drug delivery to the back of the eye following topical administration: an update on research and patenting activity","volume":"8","author":"HS Boddu","year":"2014","journal-title":"Recent Patents Drug Deliv. Formul."},{"key":"10.1016\/j.ejps.2021.105735_bib0022","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41433-018-0223-z","article-title":"Noninfectious uveitis in the Asia\u2013Pacific region","volume":"33","author":"Hsu","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.ejps.2021.105735_bib0023","series-title":"Test Method Evaluation report: Current Validation Status of in Vitro Test Methods Proposed For Identifying Eye Injury Hazard Potential of Chemicals and Products","year":"2010"},{"key":"10.1016\/j.ejps.2021.105735_bib0024","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijbiomac.2017.11.170","article-title":"Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: in-vitro characterization, ocular tolerance and antibacterial activity","volume":"108","author":"Imam","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2021.105735_bib0025","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2021.105735_bib0026","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.colsurfb.2015.03.059","article-title":"Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis","volume":"130","author":"Jaiswal","year":"2015","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejps.2021.105735_bib0027","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425247.4.4.371","article-title":"Novel approaches to retinal drug delivery","volume":"4","author":"Janoria","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2021.105735_bib0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.exer.2018.01.003","article-title":"Novel everolimus-loaded nanocarriers for topical treatment of murine experimental autoimmune uveoretinitis (EAU)","volume":"168","author":"Kasper","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejps.2021.105735_bib0029","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.colsurfb.2012.10.056","article-title":"Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery","volume":"103","author":"Katara","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejps.2021.105735_bib0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.carbpol.2013.10.079","article-title":"In situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucoma","volume":"102","author":"Katiyar","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejps.2021.105735_bib0031","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijpharm.2016.12.047","article-title":"Optimization and evaluation of Oridonin-loaded Soluplus\u00ae-Pluronic P105 mixed micelles for oral administration","volume":"518","author":"Ke","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2021.105735_bib0032","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1080\/03639045.2017.1349787","article-title":"New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment","volume":"43","author":"Li","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2021.105735_bib0033","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1016\/j.biomaterials.2012.08.047","article-title":"The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier","volume":"33","author":"Li","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2021.105735_bib0034","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/polym10091001","article-title":"Detecting Glucose Levels in Blood Plasma and Artificial Tear by Au (I) Complex on the Carbopol Polymer: a Microfluidic Paper-Based Method","volume":"10","author":"Luo","year":"2018","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ejps.2021.105735_bib0035","first-page":"2539","article-title":"Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect","volume":"9","author":"Nehoff","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2021.105735_bib0036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1869-5760-3-32","article-title":"Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study","volume":"3","author":"Nguyen","year":"2013","journal-title":"J. Ophthalmic Inflam. Infect."},{"key":"10.1016\/j.ejps.2021.105735_bib0037","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/pharmaceutics10040208","article-title":"Development and evaluation of a water soluble fluorometholone eye drop formulation employing polymeric micelle","volume":"10","author":"Noh","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2021.105735_bib0038","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/molecules24030651","article-title":"Effect of Molecular Composition of Head Group and Temperature on Micellar Properties of Ionic Surfactants with C12 Alkyl Chain","volume":"24","author":"Oremusov\u00e1","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2021.105735_bib0039","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-4182(05)80119-X","article-title":"Complications of intravitreal injection of triamcinolone acetonide","volume":"40","author":"\u00d6zkiri\u015f","year":"2005","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2021.105735_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-12-816200-2.00005-0","article-title":"Polymeric micelles as a novel carrier for ocular drug delivery","author":"\u00d6zsoy","year":"2019","journal-title":"Nanoarchitecton. Biomed."},{"key":"10.1016\/j.ejps.2021.105735_bib0041","first-page":"1397","article-title":"Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation. Artificial cells","volume":"45","author":"Pandit","year":"2017","journal-title":"Nanomed. Biotechnol."},{"key":"10.1016\/j.ejps.2021.105735_bib0042","series-title":"Systematic Review On the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior uveitis, Seminars in Arthritis and Rheumatism","first-page":"314","author":"Pato","year":"2011"},{"key":"10.1016\/j.ejps.2021.105735_bib0043","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejps.2013.04.012","article-title":"How do polymeric micelles cross epithelial barriers?","volume":"50","author":"Pepi\u0107","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105735_bib0044","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jps.24231","article-title":"Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation","volume":"104","author":"Pescina","year":"2015","journal-title":"J. Pharm Sci."},{"key":"10.1016\/j.ejps.2021.105735_bib0045","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3109\/02713683.2010.508867","article-title":"In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye","volume":"35","author":"Rafie","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejps.2021.105735_bib0046","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/02652048.2018.1425750","article-title":"Microemulsion-based delivery of triamcinolone acetonide to posterior segment of eye using chitosan and butter oil as permeation enhancer: an in vitro and in vivo investigation","volume":"35","author":"Raval","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2021.105735_bib0047","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/02652048.2018.1425750","article-title":"Microemulsion-based delivery of triamcinolone acetonide to posterior segment of eye using chitosan and butter oil as permeation enhancer: an in vitro and in vivo investigation","volume":"35","author":"Raval","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2021.105735_bib0048","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijbiomac.2016.03.064","article-title":"Dextran-PLGA-loaded docetaxel micelles with enhanced cytotoxicity and better pharmacokinetic profile","volume":"88","author":"Raza","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2021.105735_bib0049","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bjo.2006.090340","article-title":"Intraocular pressure alterations following intravitreal triamcinolone acetonide","volume":"90","author":"Rhee","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2021.105735_bib0050","first-page":"1156","article-title":"PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study. Artificial Cells","volume":"45","author":"Sah","year":"2017","journal-title":"Nanomed. Biotechnol."},{"key":"10.1016\/j.ejps.2021.105735_bib0051","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/1567201811666140115113127","article-title":"Penetration of tamoxifen citrate loaded ethosomes and liposomes across human skin: a comparative study with confocal laser scanning microscopy","volume":"11","author":"Sarwa","year":"2014","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejps.2021.105735_bib0052","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.2004.048199","article-title":"The efficacy of sirolimus in the treatment of patients with refractory uveitis","volume":"89","author":"Shanmuganathan","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2021.105735_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4155\/tde.12.122","article-title":"Nanomicelles: an emerging platform for drug delivery to the eye","volume":"4","author":"Vadlapudi","year":"2013","journal-title":"Therapeutic Deliv."},{"key":"10.1016\/j.ejps.2021.105735_bib0054","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejps.2017.03.021","article-title":"Mixed poly (vinyl pyrrolidone)-based drug-loaded nanomicelles shows enhanced efficacy against pancreatic cancer cell lines","volume":"102","author":"Veeren","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105735_bib0055","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejps.2017.08.020","article-title":"Micelle carriers based on macrogol 15 hydroxystearate for ocular delivery of terbinafine hydrochloride: in vitro characterization and in vivo permeation","volume":"109","author":"Zhou","year":"2017","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:58:20Z","timestamp":1760529500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":55,"alternative-id":["S0928098721000373"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105735","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A grafted copolymer-based nanomicelles for topical ocular delivery of everolimus: Formulation, characterization, ex-vivo permeation, in-vitro ocular toxicity, and stability study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105735"}}